Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated review

Breast cancer, the most predominant type of cancer reported in females, is a heterogeneous disease classified into various subcategories depending on the presence of hormone receptors. Epidemiological studies show a strong correlation between reduced 1,25 dihydroxy vitamin D3 (1,25(OH)2D3) levels, t...

Full description

Bibliographic Details
Main Authors: Ashok Kumar Dogra, Archana Prakash, Sanjay Gupta, Meenu Gupta, Showkat Ahmad Bhat
Format: Article
Language:English
Published: KeAi Communications Co. Ltd. 2022-01-01
Series:Advances in Biomarker Sciences and Technology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2543106422000011
_version_ 1797955394685894656
author Ashok Kumar Dogra
Archana Prakash
Sanjay Gupta
Meenu Gupta
Showkat Ahmad Bhat
author_facet Ashok Kumar Dogra
Archana Prakash
Sanjay Gupta
Meenu Gupta
Showkat Ahmad Bhat
author_sort Ashok Kumar Dogra
collection DOAJ
description Breast cancer, the most predominant type of cancer reported in females, is a heterogeneous disease classified into various subcategories depending on the presence of hormone receptors. Epidemiological studies show a strong correlation between reduced 1,25 dihydroxy vitamin D3 (1,25(OH)2D3) levels, the active component of vitamin D, and increased breast cancer risk in diverse populations. In a ligand-dependent manner, vitamin D receptor (VDR) transcriptionally modulates its target genes belonging to cell proliferation, differentiation, and apoptosis pathways, thus imparting protective function against cancer growth and progression. The coding and regulatory regions of the VDR gene contain several polymorphisms (BsmI, Fok1, Taq1, Apa1, Cdx2, poly (A), etc.) that modulate its transcription, translation, and mRNA stability. Despite this, research in this area has not yet led to many conclusions. In this review, we analyzed in a systematic way that the association of VDR allelic variants with breast cancer risk among patients from various populations. This analysis has revealed that Fok1, Bsm1, Apa1were to some extent associated with breast cancer risk, Taq1 shows no association, and Cdx2, poly(A), Tru91 gene polymorphisms may be susceptible for breast cancer development. We have highlighted the new insights of the current understanding of molecular mechanisms of the VDR gene polymorphisms related to breast cancer risk and also examined the interaction between VDR polymorphisms and steroid hormone (estrogen, progesterone, and androgen) receptors and their modifying effects on breast cancer risk, cancer severity, progression rate, and disease outcome. Therefore, with a lack of studies and inconsistent results, we recommend that further studies focus on genetic variations of the VDR gene that should be integrated with the assessment of steroid hormone receptor status in breast cancer.
first_indexed 2024-04-10T23:32:26Z
format Article
id doaj.art-07a86d9d0c4f481b92b0582653d7389b
institution Directory Open Access Journal
issn 2543-1064
language English
last_indexed 2024-04-10T23:32:26Z
publishDate 2022-01-01
publisher KeAi Communications Co. Ltd.
record_format Article
series Advances in Biomarker Sciences and Technology
spelling doaj.art-07a86d9d0c4f481b92b0582653d7389b2023-01-12T04:19:38ZengKeAi Communications Co. Ltd.Advances in Biomarker Sciences and Technology2543-10642022-01-014111Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated reviewAshok Kumar Dogra0Archana Prakash1Sanjay Gupta2Meenu Gupta3Showkat Ahmad Bhat4Department of Biochemistry, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, 248016, India; Corresponding author.Department of Biochemistry, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, 248016, IndiaDepartment of Biosciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, 248016, IndiaDepartment of Radiotherapy, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, 248016, IndiaDepartment of Biochemistry, Govt. Medical College, Doda, IndiaBreast cancer, the most predominant type of cancer reported in females, is a heterogeneous disease classified into various subcategories depending on the presence of hormone receptors. Epidemiological studies show a strong correlation between reduced 1,25 dihydroxy vitamin D3 (1,25(OH)2D3) levels, the active component of vitamin D, and increased breast cancer risk in diverse populations. In a ligand-dependent manner, vitamin D receptor (VDR) transcriptionally modulates its target genes belonging to cell proliferation, differentiation, and apoptosis pathways, thus imparting protective function against cancer growth and progression. The coding and regulatory regions of the VDR gene contain several polymorphisms (BsmI, Fok1, Taq1, Apa1, Cdx2, poly (A), etc.) that modulate its transcription, translation, and mRNA stability. Despite this, research in this area has not yet led to many conclusions. In this review, we analyzed in a systematic way that the association of VDR allelic variants with breast cancer risk among patients from various populations. This analysis has revealed that Fok1, Bsm1, Apa1were to some extent associated with breast cancer risk, Taq1 shows no association, and Cdx2, poly(A), Tru91 gene polymorphisms may be susceptible for breast cancer development. We have highlighted the new insights of the current understanding of molecular mechanisms of the VDR gene polymorphisms related to breast cancer risk and also examined the interaction between VDR polymorphisms and steroid hormone (estrogen, progesterone, and androgen) receptors and their modifying effects on breast cancer risk, cancer severity, progression rate, and disease outcome. Therefore, with a lack of studies and inconsistent results, we recommend that further studies focus on genetic variations of the VDR gene that should be integrated with the assessment of steroid hormone receptor status in breast cancer.http://www.sciencedirect.com/science/article/pii/S2543106422000011Breast cancerSteroid receptorsVitamin DVitamin D receptor (VDR) gene polymorphism
spellingShingle Ashok Kumar Dogra
Archana Prakash
Sanjay Gupta
Meenu Gupta
Showkat Ahmad Bhat
Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated review
Advances in Biomarker Sciences and Technology
Breast cancer
Steroid receptors
Vitamin D
Vitamin D receptor (VDR) gene polymorphism
title Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated review
title_full Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated review
title_fullStr Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated review
title_full_unstemmed Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated review
title_short Genetic variations of vitamin D receptor gene and steroid receptors status in breast cancer risk: An updated review
title_sort genetic variations of vitamin d receptor gene and steroid receptors status in breast cancer risk an updated review
topic Breast cancer
Steroid receptors
Vitamin D
Vitamin D receptor (VDR) gene polymorphism
url http://www.sciencedirect.com/science/article/pii/S2543106422000011
work_keys_str_mv AT ashokkumardogra geneticvariationsofvitamindreceptorgeneandsteroidreceptorsstatusinbreastcancerriskanupdatedreview
AT archanaprakash geneticvariationsofvitamindreceptorgeneandsteroidreceptorsstatusinbreastcancerriskanupdatedreview
AT sanjaygupta geneticvariationsofvitamindreceptorgeneandsteroidreceptorsstatusinbreastcancerriskanupdatedreview
AT meenugupta geneticvariationsofvitamindreceptorgeneandsteroidreceptorsstatusinbreastcancerriskanupdatedreview
AT showkatahmadbhat geneticvariationsofvitamindreceptorgeneandsteroidreceptorsstatusinbreastcancerriskanupdatedreview